| Generic Name: | Fenofibrate |
| NDA number for Tricor | 021656 |
| Label for Tricor | www.tricortablets.com |
| Label for Lipanthyl | Lipanthyl® |
|
Study ID |
Study Title |
Study Results |
Study publications |
| CFEN0203 | A randomized, double-blind trial comparing the efficacy and safety of fenofibrate, metformin, their combination and placebo in patients with metabolic syndrome |
M. Nieuwdorp, E.S.G. Stroes and J.J.P Kastelein Normalisation of metabolic syndrome using fenofibrate metformin or their combination. Diabetes. Obesity and Metabolism. 9, 2007, 869-878 |
|
| CFEN0205 | A randomised, double-blind, placebo-controlled study assessing the effect of fenofibrate, coenzyme Q10 and their co-administration on ventricular diastolic function in patients with type 2 diabetes |
Gerard T Chew and al, Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction. Diabetes Care 2008 |
|
| CLF230121-0301 | A randomized, double-blind trial assessing the efficacy and safety of low and standard doses of fenofibrate in combination with metformin on the lipid profile in patients with type 2 diabetes and dyslipidemia. |
none available |
|
|
CLF178P-0401 |
A randomised, double-blind study comparing the efficacy and safety of 145 mg NanoCrystal® fenofibrate, 10 mg ezetimibe and their combination in patients with type IIb dyslipidemia and features of the metabolic syndrome. |
none available |
|
| CLF230121-0503 | Assessment of insulin sensitivity in type 2 diabetics treated with metformin, fenofibrate and their combination |
none available |
|
|
|
|